0001209191-19-020889.txt : 20190321 0001209191-19-020889.hdr.sgml : 20190321 20190321210150 ACCESSION NUMBER: 0001209191-19-020889 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190107 FILED AS OF DATE: 20190321 DATE AS OF CHANGE: 20190321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FELLOWS DAVID A CENTRAL INDEX KEY: 0001041126 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38217 FILM NUMBER: 19698234 MAIL ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nightstar Therapeutics plc CENTRAL INDEX KEY: 0001711675 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O NIGHTSTAR, INC. STREET 2: 203 CRESCENT STREET, SUITE 303 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 781-778-7553 MAIL ADDRESS: STREET 1: C/O NIGHTSTAR, INC. STREET 2: 203 CRESCENT STREET, SUITE 303 CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: Nightstar Therapeutics Ltd DATE OF NAME CHANGE: 20170712 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2019-01-07 2019-01-09 0 0001711675 Nightstar Therapeutics plc NITE 0001041126 FELLOWS DAVID A C/O NIGHTSTAR, INC. 203 CRESCENT STREET, SUITE 303 WALTHAM MA 02453 1 1 0 0 Chief Executive Officer Ordinary Shares 2019-01-07 4 S 0 8733 12.9808 D 626395 D The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer. On January 9, 2019, a Form 4 was filed to report a transaction of the Reporting Person to cover tax liabilities pursuant to the Issuer's mandatory sell-to-cover policy. The report provided by the Issuer's equity administrator contained errors relating to the Reporting Person's holdings which have been corrected herein. This Form 4/A amends and restates, in its entirety, the original Form 4. /s/ Bryan Yoon, Attorney-in-Fact 2019-03-21